Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Nextech Invest Ltd. (CIK 1911010) reported $616.4M across 15 reported positions in its SEC 13F filing for 2024-12-31. Largest positions: RVMD ($332.5M, 53.94%), TYRA ($56.4M, 9.15%), ORIC ($42.7M, 6.92%), CRGX ($38.1M, 6.18%), ARVN ($27.0M, 4.38%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | $332.5M | 53.94% | 7.6M | Added |
| 2 | TYRA | TYRA BIOSCIENCES INC | $56.4M | 9.15% | 4.1M | Hold |
| 3 | ORIC | ORIC PHARMACEUTICALS INC | $42.7M | 6.92% | 5.3M | Hold |
| 4 | CRGX | CARGO THERAPEUTICS INC | $38.1M | 6.18% | 2.6M | Hold |
| 5 | ARVN | ARVINAS INC | $27.0M | 4.38% | 1.4M | Hold |
| 6 | MRSN | MERSANA THERAPEUTICS INC | $17.3M | 2.80% | 12.1M | Hold |
| 7 | TNGX | TANGO THERAPEUTICS INC | $17.1M | 2.77% | 5.5M | Hold |
| 8 | ZYME | ZYMEWORKS INC | $16.3M | 2.65% | 1.1M | Hold |
| 9 | RLAY | RELAY THERAPEUTICS INC | $15.8M | 2.57% | 3.8M | Hold |
| 10 | CGEM | CULLINAN ONCOLOGY INC | $13.9M | 2.25% | 1.1M | Hold |
| 11 | ALMS | ALUMIS INC | $11.6M | 1.88% | 1.5M | Hold |
| 12 | SPRY | ARS PHARMACEUTICALS INC | $9.9M | 1.60% | 936,729 | Trimmed |
| 13 | CNTX | CONTEXT THERAPEUTICS INC | $7.8M | 1.26% | 7.4M | Hold |
| 14 | SLN | SILENCE THERAPEUTICS PLC | $6.6M | 1.06% | 952,400 | Hold |
| 15 | BOLD | BOUNDLESS BIO INC | $3.6M | 0.58% | 1.2M | Hold |
Source: SEC Form 13F filings · as of 2024-12-31